Cr can either be mediated by the lymphocyte-specific granule serine esterase granperforin alone, or involves some other granule compozyme B (GraB). These molecules interact in the target nent as well, possibly another granzyme. cells to reproduce all of the features of CTL or NKAs to the major Fas-based mechanism of cytotoxicity, induced apoptosis. These include nuclear changes such it is now clear that oligomerization, probably trimerizaas chromatin condensation and finally DNA fragmention, of CD95 is necessary to attract intracellularly pretation.
formed signaling molecules. The cytoplasmic tail of Fas The mechanism of entry into target cells of GraB and contains a motif called the "death domain." This domain the mechanism by which it induces nuclear damage has can interact with the corresponding death domain of been investigated by several groups. Thus, C. Froelich the adaptor molecule Fas-associated protein with death (Northwestern University, Evanston, Illinois) C. Bleackdomain (FADD) , thus recruiting FADD to the plasma ley (University of Alberta, Edmonton, Canada), J. Trapani membrane. FADD, in turn, interacts with the caspase (Austin Research Institute, Victoria, Australia), and P.
FLICE through "death effector domains." These doHenkart (National Cancer Institute, NIH, Bethesda, mains are located at the amino terminus of FLICE and Maryland) studied in detail the respective roles of GraB at the carboxyl terminus of FADD. This interaction leads and perforin (Froelich et al., 1996; Jans et al., 1996; Shi to the assembly of the receptor-associated deathet al ., 1997) . It has been shown that GraB is endoinducing signaling complex (DISC). The DISC-bound cytosed by target cells independently of perforin, possi-FLICE induces the proteolytic activation of other membly through saturable high affinity cell surface binding bers of the caspase family resulting ultimately in sites. In the absence of added perforin, GraB shows apoptosis (Boldin et al., 1996; Muzio et al., 1996) . a cytoplasmic localization. On the other hand, when
A new family of virus-encoded inhibitors termed viral perforin is added (and presumably enters cells, through FLICE-inhibitory proteins (vFLIPs) that interferes with an as yet undefined mechanism) in about half of the apoptosis signaled via the CD95 death receptor was cells, GraB relocalizes to the nucleus. These cells that described (J. Tschopp, University of Lausanne, Switzerland). These inhibitors, which are found in particular in show GraB relocalization undergo apoptotic death. a series of ␥-herpes viruses, allow the virus to undergo by the "missing self hypothesis" (Ljunggren and Karre, 1990) . Different types of inhibitory receptors specific for replication before the host cells finally succumb. The vFLIPs are characterized by two death-effector domains groups of HLA-C (p58.1 and p58.2), HLA-B (p70), or HLA-A (p70-140) alleles have been molecularly identiwhich, similar to FLICE, are able to interact with FADD, thus competing for the recruitment of FLICE induced by fied and cloned (reviewed by . They belong to the Ig superfamily and are characterized by the oligomerization of the CD95 receptor (Thome et al., 1997) .
two or three extracellular domains. These receptors are distributed in a clonal fashion and each NK cell exCell death signaling pathways related to the Fas and TNF. R1 pathways also exist in invertebrates. A molecule presses at least one inhibitory NKR for self HLA-class I alleles. In addition, activating forms of HLA-C-specific called "reaper" was shown by H. Steller and his colleagues (White et al., 1994) to be necessary and suffireceptors have been described (p50.1, p50.2, and p50.3) that differ from the corresponding inhibitory receptors cient to induce cell death in Drosophila during development. Homology was found between the death domains in their transmembrane and cytoplasmic portions. More recently, a second class of MHC class I-specific recepand reaper (Golstein et al., 1995) . Some periodicity, such as several successive leucine residues, separated by 7 tors has been demonstrated in human NK cells Sivori et al., 1996; Lazetic et al., 1996) . These residues, was detected both in death domains of TNF-R1 and in reaper. Amino acid alignment showed NKR display a broad specificity for different HLA-class I molecules although they appear to bind preferentially that the middle third of reaper was more homologous to the death domains of TNF-R1 and DR3 (Chinnaiyan to certain groups of HLA-alleles (those belonging to the Bw6 supertypic specificity) and poorly to others (Bw4 et al., 1996) than to the death domains of Fas. Interestingly, the former are bound by TNF-R1-associated proalleles). They are formed by CD94 molecules that associate with different members of the NKG2 molecular family tein with death domain (TRADD), the latter by FADD. Thus, both the degree of homology and the connecting to form either inhibitory (CD94/NKG2A) or activating NKR (CD94/NKG2C) (A. Moretta, University of Brescia, molecules are consistent with the existence of subfamilies of death domains. Reaper would be evolutionarily Italy). Both CD94 and NKG2A molecules are type 2 transmembrane proteins belonging to the C-type lectin sucloser to one of these subfamilies (P. Golstein, INSERM-CNRS, Marseille-Luminy, France).
perfamily (reviewed by . Remarkably, both NKG2A and inhibitory NKR of the Ig Studies using gene knockout animals (E. R. Podack, University of Miami, Florida) indicated that mice defisuperfamily are characterized by intracytoplasmic immunoreceptor tyrosine based inhibition motifs (ITIM), cient for both perforin and Fas ligand expression died of severe pancreatitis, with atrophic uterus and ovary which are essential for SHP-1 phosphatase activation and induction of inhibitory signals (reviewed by Ré nard infiltrated with cells from a particular T cell subpopulation. This might be interpreted as a requirement for both et al., 1997). Because of the molecular structure, the broad specificity and the functional property, CD94/ or either the Fas or the perforin pathway for the elimination of antigen-presenting cells; thus when the latter are NKG2 complexes could represent the human counterpart of the murine Ly49 family of MHC-class I-specific not eliminated, persistent antigen presentation may lead to continuous T cell activation and tissue damage (auto-NK receptors. In view of the recent evolution of the HLAclass I system, it is likely that those NKR belonging reactive T cells?).
A novel class of Fas-activated serine/threonine kito the Ig superfamily have evolved more recently than C-type lectin NKR to adapt to the polymorphism emergnases (FASTs) that phosphorylate the RNA binding protein TIA-1 during stress-induced apoptosis has been ing in the HLA class I system (reviewed by Valiante et al., 1997) . This receptor strategy allows the NK cell sysdescribed by P. Anderson (Dana Farber Cancer Institute, Boston, Massachusetts) . TIA-1 is a component of a sigtem to sense even single allelic loss as it may occur in tumor or virally infected cells. In this context, CD94/ naling cascade that may regulate entry into apoptosis (Taupin et al., 1995) . TIA-1 binds to oligopyrimidine NKG2 complexes would represent an ancestral type of MHC-class I recognition strategy. tracts found in the 5Ј untranslated regions of mRNAs subject to stress-induced translational arrest. Some of Inhibitory NKR are also expressed on a small subset of human T lymphocytes (reviewed by Moretta et al., these mRNAs encode ribosomal subunits and survival factors such as IGF-II, hence proteins that are essential 1996). NKR ϩ T cells have been detected in peripheral blood, spleen, tonsil, and lymph nodes but not in thymus for cell growth. In response to stress, TIA-1 accumulates in the cytoplasm where it aggregates with free and and cord blood. Surface marker analysis has revealed that NKR ϩ T cells always express a memory phenotype; ER-associated ribosomes at "stress bodies." The recruitment of selected Bcl-2 family members to these moreover, in several normal donors analyzed, they are characterized by a skewed TCRV␤ repertoire. Crosslinkaggregates has been postulated to regulate entry into apoptosis.
ing of NKR leads to inhibition of different TCR-dependent and TCR-independent (e.g., NK-like cytotoxicity) MHC-Class I-Specific NK Cell Receptors In recent years, the molecular mechanisms by which NK T cell functions. The inhibitory effect exerted on TCRmediated functions has important implications. Thus, cells lyse or fail to lyse target cells have been elucidated. NK cells express receptors (NKR) that recognize MHC the expression of inhibitory NKR may result in functional impairment of specific CTLs. Preliminary data would class I molecules on target cells. The interaction between NKR and MHC class I leads to inhibition of cytosuggest that this phenomenon may occur in tumor (Ikeda et al. 1997) or virally infected patients (L. Moretta, lytic activity thus preventing lysis of normal, MHC class I positive, target cells. This mechanism was predicted University of Genoa, Italy). The fact that antigen-specific CTLs simultaneously express TCR and NKR, both recog-TAP-deficient RMA-S target cells showed that "empty" class I molecules do not protect cells from Ly49C ϩ NK nizing HLA-class I molecules but mediating opposite signals, offers new perspectives in our appreciation of cells. On the other hand, the same cells are protected after incubation in the presence of peptides binding the regulation of T cell responses and provides new clues for understanding the immunopathologic events to K b . This is in line with previous experiments on the Ly49A receptors displaying a similar peptide-depeninvolved in certain diseases. Data were also presented that are compatible with the existence of additional, still dency (Correa and Raulet, 1995) . Similar to the human NKR, a dichotomy of function between the various memunknown, inhibitory receptors in alloantigen-stimulated T cells. These cells were inhibited in their cytolytic funcbers of the Ly49 family has been demonstrated also in mice. In particular, cross-linking of Ly49A or Ly49C tion by a set of HLA-C alleles corresponding to those recognized by the p58.2 receptors; however, they did resulted in thyrosine phosphorylation of the receptors while this was not observed after cross-linking of Ly49D not react with the presently available anti-p58.2 MAbs (K. Falk, University of Munich, Germany).
(J. Ortaldo, National Cancer Institute, Frederick, Maryland). These results are consistent with both the known Recent studies indicated that the nonclassical HLAclass I molecule HLA-G, which is the only class I molestructural and functional characteristics of these Ly49 molecules, in that Ly49A, C, and G2 have ITIM motifs cule expressed by trophoblast cells, is recognized by inhibitory receptors expressed on human NK cells (Pazcontaining phosphorylation sites while Ly49D does not contain this inhibitory motif. Therefore, despite signifimany et al., 1996; Munz et al., 1997) . This issue has been discussed by H. G. Rammensee (University of Tubingen, cant divergence in their extracellular domains, human p58/p50 receptors and murine Ly49 receptors are likely Germany) who presented data suggesting that the receptors involved in HLA-G recognition may be related to share common signaling properties (reviewed by Ré -nard et al., 1997) . to the HLA-Bw4-specific p70 NKR (or NKAT-3). These data are in conflict with those reported by J. StromingViral Strategies to Elude CTL or NK Cell-Mediated MHC Recognition er's group (Pazmany et al. 1996) showing that HLA-G recognition is mediated by the HLA-C-specific p58 reIt is well known that T lymphocytes, primarily MHC class I-restricted CD8 ϩ CTL, play a major role in the control ceptors. Further studies are required to elucidate the precise contribution of the various NKR to HLA-G recogof virus infections. Some DNA viruses, on the other hand, have evolved strategies to interfere with the process of nition since other groups have recently shown that HLA-G is recognized by the CD94/NKG2A complex and MHC/viral peptide presentation to CTLs (reviewed by Spriggs, 1996) . The recent understanding of the mechanot by p58 or p70 receptors (Pende et al., 1997; PerezVillar et al., 1997) .
nisms involved in antigen presentation made possible the unraveling of several of the molecular mechanisms The need for inhibitory NKR to prevent NK-mediated lysis of self cells implies the existence of one or more by which viruses interfere with MHC class I antigen presentation. However, while downregulation of cell surface activating receptors that interact with ligand(s) expressed on target cells. However, limited information is expression of MHC class I molecules (the so-called "stealth strategy") will prevent the CTL-mediated lysis available on the surface receptors that are involved in NK cell triggering. Thus the search for new molecules of infected cells, it should render them susceptible to NK-mediated lysis (Karre and Welsh, 1997 ) (see below). capable of triggering the NK-mediated cytotoxicity is now becoming crucial for defining the molecular mecha-
The first known example of viral protein interfering with MHC class I pathway is the E19 protein of adenovinisms involved in NK cell activation/inactivation. In this context, a new molecule termed p46, has been identified rus (Andersson et al., 1985) . Since E19 molecule interacts with MHC class I molecules at the ER level, class that induces strong NK cell activation upon cross-linking by specific MAbs (S. Sivori, University of Genoa, Italy).
I molecules do not reach the cell surface, but they are retrieved from the Golgi together with E19 molecules. The p46 molecule is selectively expressed on all human NK cells, resting or activated, and the levels of cytolytic Not all the HLA-class I alleles bind equally well to E19, which therefore preferentially inhibits the expression of activity of different NK clones against HLA-negative targets correlates with the number of p46 molecules certain alleles (thus rendering cells susceptible to lysis by NK cell subsets expressing appropriate NKR). Other expressed at their cell surface. p46 is clearly distinguishable from p50 molecules (i.e., the HLA-C-specific activiruses that inhibit the MHC class I expression include members of the Herpes virus family. For example, the vating receptors) because of its molecular size, cell distribution, and distinct specificity. It may represent a Herpes simplex (HSV) encoded ICP47 molecule (York et al., 1994) binds to TAP1 and TAP2 in the cytosol and receptor for non-HLA ligands expressed on both HLA In mice, all the MHC class I-specific receptors characdifferent strategies to inhibit HLA class I expression (Fruh et al., 1997) . The US6 glycoprotein resides in the terized so far belong to the Ly49 molecular family (reviewed by Yokoyama and Seaman, 1993 In cervical cancer, HPV-16-and 18E6/E7-specific CTL (see below) were identified in peripheral blood in low Germany). It is interesting to note that NK cells play an important role in controlling both HSV and HCMV frequency, but in higher frequencies in draining lymph nodes and tumor infiltrating lymphocytes (TIL). R. E. infections. However, a potential mechanism to escape the NK cell recognition can be the expression of a Toes (University of Leiden, The Netherlands) succeeded in generating tumor-specific CTL by in vitro vaccination ␤2-binding protein with a structural homology to MHC class I heavy chain ("decoy strategy"). This protein, with recombinant adenoviruses (rAd) encoding tumorderived CTL epitopes (human adenovirus type 5 earlytermed UL18, also binds peptides (Beck and Barrell, 1988; Fahnestock et al., 1995) . Rather than interfering region 1A (Ad 5E1A), Ad5E1B and human papilloma virus type 16E7 oncoproteins) in a string-of-bead fashion. substantially with antigen presentation to T cells, UL18 has been shown to function by protecting HCMV-
The synthetic minigene-encoded CTL epitopes are processed and presented to tumor-specific CTL. rAdinfected cells against NK cell lysis (reviewed by Reyburn et al., 1997) . Recent experiments showed that UL18 immunized mice were protected against otherwise lethal challenge with tumor cells transformed by the relevant transfection into HLA class I negative target cells conferred to these cells resistance to NK-mediated lysis.
oncoproteins. The possible use of minor histocompatibility antigens The broad specificity CD94/NKG2A receptor appears to be responsible for binding UL18. Therefore HCMV has as a target for CTL-mediated specific recognition of leukemic cells (Graft versus leukemia [GvL]) has been evolved two complementary strategies to avoid identification of infected cells by both CTLs and NK cells. A emphasized. This approach would allow the elimination of the unwanted graft versus host diseases (GvHDs), corollary of the fact that HCMV has developed a mechanism for evading NK-mediated detection is that NK cells which represents a frequent and serious complication in bone marrow allograft. This approach, which is based must represent an important component of the cellmediated immune response to viral infection.
on pulsing dendritic cells with the minor histocompatibility antigen HA-1 peptide, led to the generation of CTLs Cytotoxic Lymphocytes in Immunotherapy The development of strategies for the generation of efspecific for HA-1-positive EBV transformed B cell lines (R. M. Verdijk, Leiden University Hospital, The Netherfective populations of antigen-specific CTL in immune responses against tumor or virus-infected cells reprelands). The use of viral "stealth" genes (e.g., MCMVencoded proteins [Thale et al., 1995] ) able to interfere sents a major goal of studies of both basic and applied immunology (Bolhuis et al., 1996) . In this context, Eshhar with antigen presentation by MHC class I molecules (see above) is currently being investigated in gene therapy pioneered the field of constructing chimeric receptors with tumor Ag specificity (Gross and Eshhar, 1992) . T in an attempt to avoid recipients' CTL responses to the vector or even to the therapeutic gene itself (W. Brune, lymphocytes expressing chimeric receptors with the extracellular antibody recognition unit, i.e., with antibodyMax von Pettenkofer-Institut, Munich, Germany). It appears that stealth genes themselves, outside the viral dictated specificity, efficiently lysed target cells expressing the relevant antigen. Originally, V heavy and V context, are able to protect cells from CTL-mediated lysis by lowering MHC class I expression. By using an light chains, in a single chain configuration, were linked to the signal transducing ␥ or subunits (Eshhar et al., episomally replicating plasmid vector, which allows for high and stable expression levels, cell lines were estab-1993). In a recent approach, the antibody recognition unit was connected to a CD4-CD8 transmembrane lished that express one of these genes. In contrast to the parental cell lines and mock transfected cells, these stretch directly to the intracellular Syk protein-tyrosine kinases. Making chimeric receptors with an NDF/Hecells displayed a virtually absent expression of MHC class I molecules. Transfectants derived from murine regulin binding domain (Stancowski et al., 1993) , it has been possible to functionally recognize carcinoma cells tumor cell lines can now be analyzed in established mouse model systems of tumorigenesis where CTLs overexpressing the Erb family of oncogenic receptors. R. L. H. Bolhuis and colleagues (Daniel den Hoed Cancer are known to influence tumor growth. If CTLs are not generated, the next step will aim at the insertion of the Center, Rotterdam, The Netherlands) presented data on the construction of a single chain antibody/␥ chimeric therapeutic gene into the same vector in combination with a "stealth" gene. This therapeutic gene is then exreceptor specific for renal cancer cells. They also achieved efficient retroviral gene transduction in human pected to be nonimmunogenic. Another important approach in cancer immunotherprimary T cells and optimal in vitro expansion of genemodified T lymphocytes. This work is expected to result apy is focalized on the identification of tumor-associated antigens and their peptides, which can be recin a phase I clinical study using in vitro-expanded genemodified T cells expressing renal cell cancer (RCC)-ognized by specific CTL. These studies led to the identification of numerous tumor-associated antigens specific chimeric receptors for the treatment of metastatic carcinoma. This approach may benefit from the (Coulie et al., 1994; Ikeda et al., 1997 presented by HLA-A2.1. These in vitro-generated CTL Exp. Med. 180, [35] [36] [37] [38] [39] [40] [41] [42] were capable of lysing HLA-A2.1-positive tumor cells
